Technical testing and analysis
DRUG DISCOVERY LABORATORY AS
Revenue 2025
NOK 1.1m
Operating profit
NOK 706,000
Equity
NOK 8.4m
Incorporated
1995
Share capital
NOK 100,000
Roles
Regnskapsfører
Styrets lederJo Erik Johnsrud Klaveness
VaramedlemAase Jorun Romenstad Klaveness
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| JO ERIK JOHNSRUD KLAVENESS | 100.0% | 50.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| SCANDIDERMA AS | Active | 2.1% | 5000.000000 |
| ARCTIC PHARMA AS | Active | 1.8% | 2000.000000 |
| SERCA PHARMACEUTICALS AS | Active | 0.3% | 2960.000000 |
| NACAMED AS | Active | 0.2% | 2079.000000 |
| SERODUS AS | Active | 0.1% | 22377.000000 |
| NAVAMEDIC ASA | Active | 0.1% | 14400.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.